Skip to main content

Table 2 Relation and distribution of studied risk factors to HPV DNA status

From: Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test

 

DNA results (n = 152)

p value

Negative (n = 90)

Positive (n = 62)

Age (years) Mean ± S.D.

29.53 ± 4.61

29.93 ± 5.27

0.619

Age group (n, %)

   

  21-25 years

19 (21.1 %)

14 (22.6 %)

 

  26-30 years

35 (38.9 %)

19 (30.6 %)

0.741

  31-35 years

25 (27.8 %)

19 (30.6 %)

 

  35-40 years

11 (12.2 %)

10 (16.1 %)

 

Parity

   

  Nullipara

15 (16.7 %)

10 (16.1 %)

0.930

  Multipara

75 (83.3 %)

52 (83.9 %)

 

Residence

   

  Urban

62 (68.9 %)

42 (67.7 %)

0.881

  Rural

28 (31.1 %)

20 (32.3 %)

 

Occupation

   

  Housewife

70 (77.8 %)

46 (74.2 %)

0.609

  Worker

20 (22.2 %)

16 (25.8 %)

 

Smoking

   

  No

81 (90.0 %)

55 (88.7 %)

0.799

  Yes

9 (10.0 %)

7 (11.3 %)

 

Contraception

   

  No

39 (43.3 %)

23 (37.1 %)

0.442

  Yes

51 (56.7 %)

39 (62.9 %)

 

Gynecological findings

   

  Normal (n = 97)

65

32

 

  Multiple genital warts (n = 12)

0.0 (0 %)

12 (19.4 %)

0.000

 Intermenstrual bleeding (13)

8.0 (8.9 %)

5.0 (8.1 %)

0.858

 Post-coital bleeding (30)

17 (18.9 %)

13 (21.0 %)

0.752

Distribution of HPV DNA status according to cervical cytology and biopsy results

Normal (n = 101)

90 (100)

11 (17.7)

0.000a

LSIL (n = 35)

0.0

35 (56.5)

HSIL (n = 2)

0.0

2.0 (3.2)

Invasive SCC (n = 14)

0.0

14 (22.6)

  1. a MC Monte Carlo Sig. (2-sided)